WIMI News

Updated on Monday, April 20, 2020. One biotech IPO is scheduled for the week ahead, and pipeline activity indicates that a few more may be on the way. ORIC Pharmaceuticals (ORIC), a Phase 1 biotech developing small molecule therapies for treatment resistant cancers, plans to raise $75 million at a $424 million market cap. The company's lead candidate ORIC-101...read more

The biotech industry refuses to wait. This past week saw the first IPOs since the coronavirus outbreak seized the US economy, with oncology biotech Zentalis Pharmaceuticals (ZNTL) up 29% on its first day. The IPO Index slid 8% this week, while the VIX Volatility Index is still at about triple its 2019 average. And yet, Zentalis soared and ...read more

WiMi Hologram Cloud, a Chinese provider of holographic augmented reality software for advertising, raised $26 million by offering 4.8 million ADSs at $5.50, the low end of the range of $5.50 to $7.50, to command a market value of $325 million. The company had recently increased its proposed ADS offering to 5 million from 4 million. WiMi Hologram Cloud plans to list on the...read more

Updated Monday, March 30, 2020. A biotech and a Chinese issuer are tackling a tough US IPO market in the week ahead. WiMi Hologram Cloud (WIMI) plans to raise $33 million at a $385 million market cap, underwritten by The Benchmark Company. WiMi is a leading player in China’s holographic augmented reality space, an estimated $500 million market that...read more